David Ian Quinn MBBS (Hons. I) PhD FRACP FACP undertook his early training at St. Vincent’s Hospital in Sydney before completing a PhD in Cancer Biology at the Garvan Institute and moving to the United States in 2000. Quinn is currently Executive Medical Director, Oncology Early Development at Abbvie Research and Development and Clinical Professor of Medicine in Oncology at USC Norris Clinics. He joined Abbvie in December 2021 as Senior Medical Director. Immediately prior to joining Abbvie, David was the Medical Director of the Norris Cancer Hospital and Clinics, Head, Section of Genitourinary Medical Oncology and Associate Professor of Medicine in the Division of Medical Oncology, Keck School of Medicine, University of Southern California. Prior experience includes Directorship of the Clinical Investigation Support Office and Leadership of the Genitourinary Cancer and Developmental Therapeutics Programs for the USC Norris Comprehensive Cancer Center. He is a medical oncologist with focus in the field of clinical trials and molecular correlative studies in genitourinary cancer and early therapeutics. David Quinn has published more than 200 papers, reviews and chapters including recent publications in New England Journal of Medicine, Nature, Lancet Oncology, Lancet, Journal of the National Cancer Institute, Cell Stem Cells and Journal of Clinical Oncology. He is a reviewer for more than 50 peer-reviewed journals, is on the editorial boards of American Journal of Clinical Oncology, cancer.net (American Society of Clinical Oncology), Bladder Cancer and Annals of Oncology and has been an invited speaker in more than 30 countries. Dr. Quinn was previously a member of the NCI Prostate Cancer Task Force after stepping down from the Renal Cancer Task Force after 6 years, Chair of the Department of Defense Prostate Cancer Research Program Integration Panel, Co-Chair for Genitourinary Cancer in the California Cancer Consortium and is SWOG organ site chair for advanced prostate cancer (2012-21).